Global Blood Glucose Monitoring System Market – Growth Factor, Analysis and Forecast 2024

Diabetes mellitus is the group of chronic endocrine disorder due to insufficient level of insulin. Prolonged hyperglycemia (high blood sugar) can lead to severe complications including cardiovascular disease, kidney failure, diabetic retinopathy or nephropathy, and ulcers. Blood glucose monitoring systems are used for the testing of blood glucose level in the body. The global blood glucose monitoring system market is growing at significant rate due to increasing prevalence of diabetes. The market is expected to grow at the faster rate for continuous blood glucose monitoring products in the coming years due to increasing adoption of minimally invasive procedure.

Get Free Report Sample at: https://www.vynzresearch.com/healthcare/blood-glucose-monitoring-system-market/request-sample

There are two types of blood glucose monitoring system, self-monitoring blood glucose systems and continuous monitoring blood glucose system. Of both the types the continuous monitoring blood glucose system market is expected to grow at the higher growth rate, due to increasing adoption of minimally invasive procedure.

On the basis of testing site, the blood glucose monitoring system market is segment into fingertip testing and alternate site testing. Fingertip testing is the most common technique used for measurement of blood glucose level. Fingertip testing segment has the larger share and is also expected to grow at the faster rate due to high reliability and accuracy of fingertip testing.

Geographically, North America is the largest blood glucose monitoring system market as the region has favorable reimbursement policies, increasing awareness program and rising FDA approvals. Increasing prevalence of diabetes has fueled the growth of the North American blood glucose monitoring system market. For instance, according to Centers for Disease Control and Prevention (CDC), in 2015, approximately 23.1 million people in the U.S. had diabetes.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/blood-glucose-monitoring-system-market

Asia-Pacific is observed to witness the fastest growth in demand for blood glucose monitoring products. Increasing prevalence of diabetes, increasing awareness of diabetes, increasing healthcare expenditure, and large population base are creating a positive impact on the blood glucose monitoring systems market growth in the region.

Key players in the blood glucose monitoring system market are investing in the development of innovative and advance products, which is strengthening their position in the market. In September 2016, Abbott gained FDA approval for the FreeStyle Libre Pro continuous glucose monitoring (CGM) device, a professional-use device to provide better diabetes management to diabetes patient. In addition, in August 2016, Roche launched the Accu-Chek Guide, the next-generation blood glucose monitoring system. Abbott Laboratories, B. Braun Melsungen, F. Hoffmann-La Roche, Ypsomed, Lifescan, Medtronic, Ascensia Diabetes Care, Dexcom, Nipro and Sanofi are the key players offering blood glucose monitoring products.

About VynZ Research : 

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | Twitter | Facebook | Google+

This release was published on openPR.